UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Targeting glucose metabolism to develop anticancer treatments and therapeutic patents Review article
2022
Authors:  Zhou, Yan;  Guo, Yizhen;  Tam, Kin Yip
Favorite | TC[WOS]:23 TC[Scopus]:23  IF:5.4/6.4 | Submit date:2022/05/17
Cancer Glucose Metabolism  Cancer Treatment Patent  Glycolytic Inhibitor  Hexokinase 2 (Hk2)  Lactate Dehydrogenase a (Ldha)  Pyruvate Dehydrogenase Kinase (Pdk)  Warburg Effect  
Targeting glucose metabolism to develop anticancer treatments and therapeutic patents Journal article
Zhou Yan, Guo Yizhen, TAM KIN YIP. Targeting glucose metabolism to develop anticancer treatments and therapeutic patents[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32(4), 441-453.
Authors:  Zhou Yan;  Guo Yizhen;  TAM KIN YIP
Adobe PDF | Favorite | TC[WOS]:23 TC[Scopus]:23  IF:5.4/6.4 | Submit date:2024/08/29
Cancer Treatment Patent  Cancer Glucose Metabolism  Warburg Effect  Hexokinase 2 (Hk2)  Pyruvate Dehydrogenase Kinase (Pdk)  Lactate Dehydrogenase a (Ldha)  Glycolytic Inhibitor  
GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling Journal article
White, Mark A., Tsouko, Efrosini, Lin, Chenchu, Rajapakshe, Kimal, Spencer, Jeffrey M., Wilkenfeld, Sandi R., Vakili, Sheiva S., Pulliam, Thomas L., Awad, Dominik, Nikolos, Fotis, Katreddy, Rajasekhara Reddy, Kaipparettu, Benny Abraham, Sreekumar, Arun, Zhang, Xiaoliu, Cheung, Edwin, Coarfa, Cristian, Frigo, Daniel E.. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling[J]. ENDOCRINE-RELATED CANCER, 2018, 25(4), 453-469.
Authors:  White, Mark A.;  Tsouko, Efrosini;  Lin, Chenchu;  Rajapakshe, Kimal;  Spencer, Jeffrey M.; et al.
Favorite | TC[WOS]:47 TC[Scopus]:49  IF:4.1/4.4 | Submit date:2018/10/30
Glut12  Slc2a12  Glucose Metabolism  Androgen Receptor (Ar)  Calcium/calmodulin-dependent Protein Kinase Kinase 2 (Camkk2)  5 '-amp-activated Protein Kinase (Ampk)  Prostate Cancer